Position in NVAX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$379,880
+$293,306 QoQ
Shares Held
40,327
+193.5% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#105
of 263 holders
Holding Since
Jun 2021
6 quarters on record
Voting authority
Sole 19%
Shared 0%
None 81%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MERCER GLOBAL ADVISORS INC /ADV holds $289,525,211 across 340 Biotechnology names. NVAX ranks #53 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
941,283 | $124,936,492 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
30,435 | $15,117,977 | |
| 3 | INCY |
Incyte Corp
|
116,069 | $13,157,581 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
20,094 | $12,529,412 | |
| 5 | CAPR |
Capricor Therapeutics, Inc.
|
402,731 | $9,697,762 | |
| 6 | EXEL |
Exelixis, Inc.
|
175,488 | $9,548,302 | |
| 7 | ORMP |
Oramed Pharmaceuticals Inc.
|
1,910,540 | $9,189,697 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
102,823 | $8,940,459 |
All Filings in NVAX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $379,880 | 40,327 | Shares | Sole | 2026-08-11 | |
| 2025-06-30 | $86,574 | 13,742 | Shares | Sole | 2025-08-14 | |
| 2022-03-31 | $217,120 | 2,948 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $331,350 | 2,316 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $568,029 | 2,740 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $420,161 | 1,979 | Shares | Sole | 2021-08-10 | |
| No filing history on record for this holder in this stock. | ||||||